Newstral
Article
jdsupra.com on 2023-11-02 01:06
FDA: New Draft Guidance on Communication of Unapproved Uses of Approved or Cleared Medical Products
Related news
- FDA Revises Guidance Concerning Scientific Communications to HCPs about Unapproved Uses of Approved/Cleared Medical Productsjdsupra.com
- FDA Issues Draft Guidance on Providing Health Care Providers With Scientific Information on Unapproved Uses of Approved/Cleared Medical Productsjdsupra.com
- FDA broadens scope on communication about unapproved uses to HCPsjdsupra.com
- FDA Issues Revised Draft Guidance on “Scientific Information on Unapproved Uses Communications”jdsupra.com
- FDA Cracks Down on Unapproved Eye Productsjdsupra.com
- FDA Releases Final Guidance: Transition of Previously Approved Drugs to Being "Deemed Licensed" Biologicsjdsupra.com
- FDA cracks down on unapproved ear dropswkrg.com
- FDA pulls unapproved prescription ear dropsKnoxville News Sentinel
- FDA Cracks Down On Unapproved Ear DropsWBNS-10TV
- FDA Reinstates Unapproved New Drug Initiativejdsupra.com
- FDA Releases Naming Guidancejdsupra.com
- DFDA approved salmondanbyink.bangordailynews.com
- UFDA issues warning to pet companies for selling unapproved antibioticsupi.com
- FDA to Prioritize Enforcement Actions Against Unapproved Homeopathic Drugsjdsupra.com
- TEditorial: FDA must get rid of unapproved herbal productsthechronicle.com.gh
- Guidance from FDA Clarifies a Key Issue for Industry: Non-Promotional Presentations About Unapproved Uses of Medical Products Can Be Produced by the Products’ Sponsors Without Violating Off-Label Rulesjdsupra.com
- FDA Releases Public Inventory of Unapproved Food Additivesjdsupra.com
- FDA Will Hold Hearing on Communications Regarding Unapproved Usesjdsupra.com
- FDA and FTC Warn Against Making Unapproved COVID-19 Claimsjdsupra.com